Metabolic associated steatotic liver disease (MASLD), formerly known as non-alcoholic fatty liver disease (NAFLD), and metabolic-associated steatohepatitis (MASH), formerly known as non-alcoholic steatohepatitis (NASH), are conditions linked to obesity and insulin resistance
They are prepared by licensed pharmacies following federal and state compounding rules - but they haven't been through the extensive clinical trial process and manufacturing inspections that FDA-approved drugs undergo
Compared to the control group (which has high levels of glutathione), the amiodarone administered group showed dramatically reduced glutathione levels at each time interval, which shows the reduced detoxification capacity of mitochondria
Ahrens, W
Additionally, because both drugs cause delayed gastric emptying, they can potentially affect the absorption of other medications taken by mouth
Only 13 states not including West Virginia cover the drugs for obesity treatment